Literature DB >> 1924432

Differential induction of interleukin-6 production by monocytes, endothelial cells and smooth muscle cells.

M Helle1, L Boeije, D Pascual-Salcedo, L Aarden.   

Abstract

Studying the production of IL-6 by monocytes, endothelial cells and smooth muscle cells we observed that cytokine inducers like IL-1, TNF alpha, LPS, SAC and PMA could be divided roughly into two categories. One, that consisted of LPS and SAC, which had a potent IL-6 inducing effect on monocytes and minor or no effect on endothelial- and smooth muscle cells. The other category, consisting of IL-1, TNF alpha and PMA, induced IL-6 production in endothelial- and smooth muscle cells and of which IL-1 also induced IL-6 in monocytes. Only IL-1 induced IL-6 production in monocytes as well as in endothelial cells and smooth muscle cells. Besides IL-6, also IL-1 and TNF alpha were produced by monocytes however with different kinetics. None of the stimuli had any inhibitory effect on IL-6 production with the exception of PMA. Whereas PMA induced IL-6 production in endothelial cells and it potentiated the induction of IL-6 by IL-1 in these cells, it inhibited LPS-stimulated IL-6 production in monocytes. In line with the effects of PMA, staurosporin induced IL-6 production in monocytes and it inhibited IL-1 driven IL-6 production by endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1924432

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  2 in total

1.  C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms.

Authors:  Simon Schimmack; Yongchao Yang; Klaus Felix; Markus Herbst; Yixiong Li; Miriam Schenk; Frank Bergmann; Thilo Hackert; Oliver Strobel
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

2.  Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Juan Zhang; Peng Wang; Huaqiang Ouyang; Jianhua Yin; Aihua Liu; Chunzheng Ma; Luming Liu
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.